Schedule 13d

Filed by: ADVOCAT INC
Subject Company: ADVOCAT, INC.
Filed as of Date: 05/07/2008
View Original Filing on Edgar's
0001019687-08-002043.txt : 20080507
<SEC-HEADER>0001019687-08-002043.hdr.sgml : 20080507
<ACCEPTANCE-DATETIME>20080507083529
ACCESSION NUMBER:		0001019687-08-002043
CONFORMED SUBMISSION TYPE:	SC 13D/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20080507
DATE AS OF CHANGE:		20080507

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BRISTOL INVESTMENT FUND LTD
		CENTRAL INDEX KEY:			0001174866
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		SC 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		CALEDONIAN HOUSE
		STREET 2:		JENNETT STREET, GEORGE TOWN
		CITY:			GRAND CAYMAN
		STATE:			E9
		ZIP:			#

	MAIL ADDRESS:	
		STREET 1:		CALEDONIAN HOUSE
		STREET 2:		JENNETT STREET, GEORGE TOWN
		CITY:			GRAND CAYMAN
		STATE:			E9
		ZIP:			#

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BRISTOL INVESTMENT FUND INC
		DATE OF NAME CHANGE:	20020605

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ADVOCAT INC
		CENTRAL INDEX KEY:			0000919956
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-SKILLED NURSING CARE FACILITIES [8051]
		IRS NUMBER:				621559667
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-43225
		FILM NUMBER:		08808273

	BUSINESS ADDRESS:	
		STREET 1:		1621 GALLERIA BLVD.
		CITY:			BRENTWOOD
		STATE:			TN
		ZIP:			37027
		BUSINESS PHONE:		6157717575

	MAIL ADDRESS:	
		STREET 1:		1621 GALLERIA BLVD.
		CITY:			BRENTWOOD
		STATE:			TN
		ZIP:			37027
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D/A
<SEQUENCE>1
<FILENAME>bristol_advocat13da2-050608.txt
<DESCRIPTION>AMENDMENT NO. 2
<TEXT>
<PAGE>

                                                                OMB APPROVAL
                                                           OMB Number: 3235-0145
                                                      Expires: December 31, 2005
                                                        Estimated average burden
                                                      hours per response. . . 11

- --------------------------------------------------------------------------------

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                 SCHEDULE 13D/A

                    UNDER THE SECURITIES EXCHANGE ACT OF 1934
                               (AMENDMENT NO. 2)*


                                  Advocat Inc.
- --------------------------------------------------------------------------------
                                (Name of Issuer)


                                  Common Stock
- --------------------------------------------------------------------------------
                         (Title of Class of Securities)


                                    007586100
- --------------------------------------------------------------------------------
                                 (CUSIP Number)


                                 Amy Wang, Esq.
                          Bristol Capital Advisors, LLC
           10990 Wilshire Boulevard, Suite 1410, Los Angeles, CA 90024
                                 (310) 696-0333
- --------------------------------------------------------------------------------


                  (Name, Address and Telephone Number of Person
                Authorized to Receive Notices and Communications)

                                   May 6, 2008
- --------------------------------------------------------------------------------
             (Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of ss.ss.240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the
following box. [ ]

NOTE: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See ss.240.13d-7 for other
parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).

<PAGE>

CUSIP No.   007586100
- --------------------------------------------------------------------------------


      1. Names of Reporting Persons. I.R.S. Identification Nos. of above
         persons (entities only).

           Bristol Investment Fund, Ltd.

- --------------------------------------------------------------------------------

      2. Check the Appropriate Box if a Member of a Group (See Instructions)
         (a)   ...............................................................
         (b)   ...............................................................

- --------------------------------------------------------------------------------

      3. SEC Use Only.........................................................

- --------------------------------------------------------------------------------

      4. Source of Funds (See Instructions)
           Cash

- --------------------------------------------------------------------------------

      5. Check if Disclosure of Legal Proceedings Is Required Pursuant to
         Items 2(d) or 2(e) ..................................................

- --------------------------------------------------------------------------------

      6. Citizenship or Place of Organization
           Cayman Islands

- --------------------------------------------------------------------------------

            7. Sole Voting Power
                 294,834

- --------------------------------------------------------------------------------
            8. Shared Voting Power


- --------------------------------------------------------------------------------
            9. Sole Dispositive Power
                 294,834

- --------------------------------------------------------------------------------
           10. Shared Dispositive Power


- --------------------------------------------------------------------------------
     11. Aggregate Amount Beneficially Owned by Each Reporting Person
           294,834

- --------------------------------------------------------------------------------

     12. Check if the Aggregate Amount in Row (11) Excludes Certain Shares
         (See Instructions) ..................................................

- --------------------------------------------------------------------------------

     13. Percent of Class Represented by Amount in Row (11)
           5.13%

- --------------------------------------------------------------------------------

     14. Type of Reporting Person (See Instructions)
           CO

- --------------------------------------------------------------------------------

<PAGE>

The following constitutes Amendment No. 2 ("Amendment No. 2") to the Schedule
13D filed by the undersigned. This Amendment No. 2 amends the Schedule 13D as
specifically set forth herein.

Item 4 is amended to include the following:

ITEM 4.  PURPOSE OF TRANSACTION

Bristol Investment Fund, Ltd. ("Bristol") is withdrawing its nomination of two
(2) nominees for election to the Board of Directors (the "Board") of the Company
at the 2008 annual meeting of stockholders of the Company (the "Annual
Meeting"). Bristol has decided to withdraw its nominees for election to Board in
light of the Company's inclusion of Bristol's shareholder proposal in its
definitive proxy. Bristol believes that its shareholder proposal provides a
meaningful method for shareholders to express their concerns about the Company
and management.
The Reporting Person reserves the right to communicate with the Issuer's board
of directors and management, communicate with the Issuer's shareholders directly
or through shareholder proposals, call a special meeting of shareholders,
communicate directly with potential acquirers of Issuer, purchase additional
Shares, sell some or all of its Shares, nominate candidates for election to the
board of directors, or change its intention with respect to any and all matters
referred to in this Item 4.

                                    SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
Dated:  May 6, 2008

BRISTOL INVESTMENT FUND, LTD.


By: /s/ Paul Kessler
</TEXT>
</DOCUMENT>